NOT KNOWN DETAILS ABOUT SLEEPING PILLS

Steer clear of concomitant use of tucatinib with CYP3A substrates, where by minimum concentration modifications may bring about serious or daily life-threatening toxicities. If unavoidable, minimize CYP3A substrate dose In line with product labeling.phenobarbital will reduce the extent or result of diazepam by impacting hepatic/intestinal enzyme CY